Publication:
Lack of Association between Prohibitin 3’ Untranslated Region C—>T Polymorphism and Breast Cancer in a Turkish Population

dc.authorscopusid24781203900
dc.authorscopusid6603455076
dc.authorscopusid9732974500
dc.contributor.authorKarakuş, N.
dc.contributor.authorKara, N.
dc.contributor.authorUlusoy, A.N.
dc.date.accessioned2020-06-21T15:13:18Z
dc.date.available2020-06-21T15:13:18Z
dc.date.issued2008
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Karakuş] Nevin, Department of Medical Biology and Genetics, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medical Biology and Genetics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kara] Nurten, Department of Medical Biology and Genetics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ulusoy] Ali Naki, Department of General Surgery, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThe 3′ untranslated region (3′UTR) of the prohibitin gene has a positive effect on arresting cell proliferation between G1 and S phases and inhibits DNA synthesis. A C-to-T transition within this region creates a variant that alters mRNA function and has been shown to be associated with an increased breast cancer risk among young North Americans who are under 50 years and have at least one first-degree relative with breast cancer. We carried out a population-based case-control study to assess whether this association exists in Turkish women. We examined 106 breast cancer patients and 154 healthy controls by PCR and restriction fragment length polymorphism analysis. In the prohibitin 3′UTR, we did not detect a difference in CT/TT genotype frequency (p = 0.694; odds ratio [OR], 1.106; 95% confidence intervals [CI], 0.659-1.86) or in C/T allele frequency (p = 0.850; OR, 1.043; 95% CI, 0.667-1.62) between the all breast cancer patients and the controls. The results did not change in subgroups defined by age or family history. Hence our results do not lend support to the hypothesis that this polymorphism contributes to risk of breast cancer. The prohibitin T variant is not associated with the risk of breast cancer in Turkish women. © Copyright 2008, Mary Ann Liebert, Inc.en_US
dc.identifier.doi10.1089/dna.2007.0724
dc.identifier.endpage452en_US
dc.identifier.issn1044-5498
dc.identifier.issn1557-7430
dc.identifier.issue8en_US
dc.identifier.pmid18494604
dc.identifier.scopus2-s2.0-51649093861
dc.identifier.scopusqualityQ2
dc.identifier.startpage449en_US
dc.identifier.urihttps://doi.org/10.1089/dna.2007.0724
dc.identifier.volume27en_US
dc.identifier.wosWOS:000259126600006
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherMary Ann Liebert Incen_US
dc.relation.ispartofDNA and Cell Biologyen_US
dc.relation.journalDna and Cell Biologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleLack of Association between Prohibitin 3’ Untranslated Region C—>T Polymorphism and Breast Cancer in a Turkish Populationen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files